KAREN ZANNI: Open Payments
NPI 1255714069 · LEEDS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Alkermes, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: Wegovy, TRINTELLIX, ARISTADA, REXULTI, AUSTEDO XR, SPRAVATO, VRAYLAR, CONTRAVE.
Industry payments across MA — which companies pay providers there.
